Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

acquired idiopathic inflammatory myopathy News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A French study reveals a notable increase in the incidence of idiopathic inflammatory myopathies following the SARS-CoV-2 outbreak. This research utilizes national health data and myositis-specific autoantibody data to highlight the potential long-term effects of COVID-19 on muscle-related diseases.

A systematic review highlights the autoimmune spectrum associated with combined pulmonary fibrosis and emphysema, including cases of inflammatory myopathy. This research could inform future studies and treatment approaches for these interconnected conditions.

A study from Southwestern Saudi Arabia examines the clinical characteristics and malignancy prevalence in idiopathic inflammatory myopathies. This research contributes to understanding the disease's impact and associated cancer risks.

A case report highlights acquired idiopathic generalized anhidrosis as a late-onset immune-related adverse event in a lung adenocarcinoma patient treated with pembrolizumab. This finding contributes to the understanding of potential side effects associated with immune checkpoint inhibitors.

A recent study highlights the increased risk of second primary cancers and mortality in patients with idiopathic inflammatory myopathies. This research underscores the need for ongoing monitoring and management strategies in this patient population.

Not rare diseases news,news about your rare disease.

Earlier

A systematic review highlights the autoimmune spectrum associated with combined pulmonary fibrosis and emphysema, including cases of inflammatory myopathy. This research could inform future studies and treatment approaches for these interconnected conditions.

A study from Southwestern Saudi Arabia examines the clinical characteristics and malignancy prevalence in idiopathic inflammatory myopathies. This research contributes to understanding the disease's impact and associated cancer risks.

A case report highlights acquired idiopathic generalized anhidrosis as a late-onset immune-related adverse event in a lung adenocarcinoma patient treated with pembrolizumab. This finding contributes to the understanding of potential side effects associated with immune checkpoint inhibitors.

A recent study highlights the increased risk of second primary cancers and mortality in patients with idiopathic inflammatory myopathies. This research underscores the need for ongoing monitoring and management strategies in this patient population.

Not rare diseases news,
news about your rare disease.